Hepatitis B and Renal Disease

Overview

Journal Curr Hepat Rep

Publisher Springer

Date 2010 May 13

PMID 20461128

Citations 19

Authors

Tak Mao Chan

Affiliations

Soon will be listed here.

Abstract

Glomerulonephritis is an important extrahepatic manifestation of chronic hepatitis B virus (HBV) infection. The uncommon occurrence, variability in renal histopathology, and heterogeneity in clinical course present challenges in clinical studies and have resulted in a relative paucity of data and uncertainty with regard to the optimal management of HBV-related glomerular diseases. The advent of nucleos(t)ide analogue medications that effectively suppress HBV replication has markedly altered the clinical outcomes of kidney transplant recipients with HBV infection, but the emergence of drug resistance is an escalating problem. This article reviews the recent knowledge of the pathogenesis and treatment of HBV-related membranous nephropathy, and discusses the management of hepatitis B in kidney transplant recipients, which is continuously evolving.

Citing Articles

Hepatitis B virus infection as a risk factor for chronic kidney disease: a systematic review and meta-analysis.

Chen D, Yu R, Yin S, Qiu W, Fang J, Peng X BMC Infect Dis. 2024; 24(1):620.

PMID: 38909191 PMC: 11193185. DOI: 10.1186/s12879-024-09546-z.

Podocyte-targeted therapies - progress and future directions.

Meliambro K, He J, Campbell K Nat Rev Nephrol. 2024; 20(10):643-658.

PMID: 38724717 DOI: 10.1038/s41581-024-00843-z.

Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis B Virus Infections.

Songtanin B, Chaisrimaneepan N, Mendoza R, Nugent K Viruses. 2024; 16(4).

PMID: 38675959 PMC: 11055091. DOI: 10.3390/v16040618.

Urinary immunoglobulins in viral diagnosis: An overview.

Mohandas S, Balan S, Mourya D Indian J Med Res. 2022; 155(1):11-21.

PMID: 35859424 PMC: 9552372. DOI: 10.4103/ijmr.IJMR_808_18.

Risk Factors of Chronic Kidney Disease in Chronic Hepatitis B: A Hospital-based Case-control Study from China.

Liu Y, Wang X, Xu F, Li D, Yang H, Sun N J Clin Transl Hepatol. 2022; 10(2):238-246.

PMID: 35528983 PMC: 9039709. DOI: 10.14218/JCTH.2021.00082.

References

Lisker-Melman M, Webb D, Di Bisceglie A, Kassianides C, MARTIN P, Rustgi V . Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon. Ann Intern Med. 1989; 111(6):479-83. DOI: 10.7326/0003-4819-111-6-479. View

Orito E, Ichida T, Sakugawa H, Sata M, Horiike N, Hino K . Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology. 2001; 34(3):590-4. DOI: 10.1053/jhep.2001.27221. View

Finelli L, Miller J, Tokars J, Alter M, Arduino M . National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial. 2005; 18(1):52-61. DOI: 10.1111/j.1525-139X.2005.18108.x. View

Nangaku M, Couser W . Mechanisms of immune-deposit formation and the mediation of immune renal injury. Clin Exp Nephrol. 2005; 9(3):183-91. DOI: 10.1007/s10157-005-0357-8. View

Motta J, Mello F, Lago B, Perez R, Gomes S, Figueiredo F . Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis. J Gastroenterol Hepatol. 2009; 25(1):101-6. DOI: 10.1111/j.1440-1746.2009.05972.x. View

Tse K, Yung S, Tang C, Yip T, Chan T . Management of hepatitis B reactivation in patients with lupus nephritis. Rheumatol Int. 2009; 29(11):1273-7. DOI: 10.1007/s00296-008-0823-1. View

Conjeevaram H, Hoofnagle J, Austin H, Park Y, Fried M, Di Bisceglie A . Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology. 1995; 109(2):540-6. DOI: 10.1016/0016-5085(95)90343-7. View

Huang Y, Liu C, Lai M, Lee P, Tsai M, Wang S . Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series. Clin Ther. 2006; 28(9):1327-34. DOI: 10.1016/j.clinthera.2006.09.011. View

Zeng C, Chen H, Wang R, Chen Y, Zhang S, Liu L . Etiology and clinical characteristics of membranous nephropathy in Chinese patients. Am J Kidney Dis. 2008; 52(4):691-8. DOI: 10.1053/j.ajkd.2008.06.006. View

10.

Filler G, Feber J, Weiler G, Le Saux N . Another case of HBV associated membranous glomerulonephritis resolving on lamivudine. Arch Dis Child. 2003; 88(5):460. PMC: 1719544. DOI: 10.1136/adc.88.5.460. View

11.

Lai K, Li P, Lui S, Au T, Tam J, Tong K . Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med. 1991; 324(21):1457-63. DOI: 10.1056/NEJM199105233242103. View

12.

Han D, Kim T, Park S, Lee S, Kim S, Yang W . Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: comparison with salvage treatment after hepatic dysfunction with HBV recurrence. Transplantation. 2001; 71(3):387-94. DOI: 10.1097/00007890-200102150-00008. View

13.

Deng C, Song X, Liang H, Feng C, Sheng Y, Wang M . Chronic hepatitis B serum promotes apoptotic damage in human renal tubular cells. World J Gastroenterol. 2006; 12(11):1752-6. PMC: 4124352. DOI: 10.3748/wjg.v12.i11.1752. View

14.

Connor F, Rosenberg A, Kennedy S, Bohane T . HBV associated nephrotic syndrome: resolution with oral lamivudine. Arch Dis Child. 2003; 88(5):446-9. PMC: 1719558. DOI: 10.1136/adc.88.5.446. View

15.

Chan T, Fang G, Tang C, Cheng I, Lai K, Ho S . Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients. Hepatology. 2002; 36(5):1246-52. DOI: 10.1053/jhep.2002.36156. View

16.

Bhimma R, Coovadia H, Adhikari M . Hepatitis B virus-associated nephropathy in black South African children. Pediatr Nephrol. 1998; 12(6):479-84. DOI: 10.1007/s004670050492. View

17.

Chan T, Tse K, Tang C, Lai K, Ho S . Prospective study on lamivudine-resistant hepatitis B in renal allograft recipients. Am J Transplant. 2004; 4(7):1103-9. DOI: 10.1111/j.1600-6143.2004.00467.x. View

18.

Terrault N, Adey D . The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol. 2007; 2(3):563-75. DOI: 10.2215/CJN.02930806. View

19.

Minuk G, Sun D, Greenberg R, Zhang M, Hawkins K, Uhanova J . Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology. 2004; 40(5):1072-7. DOI: 10.1002/hep.20435. View

20.

Levy M, Chen N . Worldwide perspective of hepatitis B-associated glomerulonephritis in the 80s. Kidney Int Suppl. 1991; 35:S24-33. View